Research
And Grants
To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $18,897,055 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 119 grants at over 100 hospitals in 17 countries.
Gustave Roussy - $101,868
$101,868.00
October 2017
Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG
Ospedale Pediatrico Bambino Gesu - $98,987
$98,987.00
October 2017
Investigating the role of DIPG-derived exosomes in tumor growth and invasion
Memorial Sloan Kettering Cancer Center - $100,000
$100,000.00
October 2017
Targeting EZH2 as a therapeutic strategy in DIPG
Dana-Farber Cancer Institute - $100,000
$100,000.00
October 2017
Defining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-sequencing analyses
The Hospital of Sick Children - $162,828
$162,828.00
October 2017
Targeting DIPG through pharmacological activation of mitochondrial biogenesis: an in vitro and in vivo preclinical study
Stanford University - $200,000
$200,000.00
October 2017
Targeting neuronal activity regulated DIPG infiltration
Children's Cancer Institute (AU) - $185,706
$185,706.00
October 2017
Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1
Children's National Medical Center - $200,000
$200,000.00
October 2017
Validation of TAK228 as an effective drug for treating children with DIPG